Overview

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Status:
Completed
Trial end date:
2014-01-10
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the efficacy, safety, and tolerability of cariprazine relative to placebo for the treatment of participants with bipolar depression.
Phase:
Phase 2
Details
Lead Sponsor:
Forest Laboratories
Collaborator:
Gedeon Richter Ltd.
Treatments:
Cariprazine